Yeast central nervous system infection in a critically ill patient: a case report

Frantzeska Frantzeskaki1, Chryssi Diakaki, Michalis Rizos

  • 12nd Department of Critical Care, University Hospital ATTIKON, Athens, Greece. ffrantzeska@gmail.com.

Abstract

Insights

Invasive fungal infections pose a significant threat to intensive care unit (ICU) patients, often leading to poor outcomes. This case highlights a rare yeast central nervous system infection, emphasizing diagnostic and therapeutic challenges in critically ill individuals.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Mycology

Background:

  • Invasive fungal infections (IFIs) are prevalent in intensive care units (ICUs), contributing to increased morbidity and mortality.
  • Risk factors for IFIs include central venous catheters, broad-spectrum antibiotics, parenteral nutrition, renal replacement therapy, and immunosuppression.
  • Diagnosis can be complicated, often requiring tissue cultures, and treatment is challenging due to rising antifungal resistance.

Observation:

  • A rare case of yeast central nervous system infection in a 28-year-old Greek man is presented.
  • This case underscores the diagnostic and therapeutic difficulties encountered in managing IFIs in critically ill patients.

Findings:

  • Difficult-to-treat fungal infections can significantly complicate the clinical course of critically ill patients.
  • The prognosis for patients with IFIs can be unfavorable due to treatment challenges and increasing antifungal resistance.

Implications:

  • This report emphasizes the need for thorough investigation and effective treatment strategies for fungal infections in critically ill patients.
  • Understanding rare and difficult-to-treat fungal infections is crucial for improving patient outcomes in intensive care settings.

Related Concept Videos